Literature DB >> 25314931

Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysis.

Stefania Gori1, Gianluigi Lunardi1, Alessandro Inno2, Roberto Magarotto1, Simona Duranti1, Michele Giuseppe Messa3, Claudio Mucchino4, Massimo Cirillo1.   

Abstract

Entities:  

Keywords:  Dose reduction; FLOX; FOLFOX; Free platinum; Hemodialysis

Mesh：

Substances：

Year:  2014        PMID： 25314931     DOI： 10.1016/j.clcc.2014.09.003

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  6 in total

1.  Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan.

Authors:  Taro Funakoshi; Takahiro Horimatsu; Michio Nakamura; Koichi Shiroshita; Koichi Suyama; Masashi Mukoyama; Takuro Mizukami; Tsutomu Sakurada; Eishi Baba; Kazuhiko Tsuruya; Akira Nozaki; Kensei Yahata; Yukinori Ozaki; Yoshifumi Ubara; Hisateru Yasui; Akihiro Yoshimoto; Shingo Fukuma; Naoya Kondo; Takeshi Matsubara; Kazuo Matsubara; Shunichi Fukuhara; Motoko Yanagita; Manabu Muto
Journal:  ESMO Open       Date:  2018-02-23

2.  Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature.

Authors:  Chikako Funasaka; Yusuke Kanemasa; Tatsu Shimoyama; Akihito Ohta; Yasushi Omuro
Journal:  Case Rep Oncol       Date:  2019-08-16

3.  Treatment of Gastric and Gastroesophageal Cancer Patients with Hemodialysis by CapeOX.

Authors:  Kenta Sasaki; Qiliang Zhou; Yoshifumi Matsumoto; Takuro Saiki; Masato Moriyama; Yasuo Saijo
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

4.  Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report.

Authors:  Danping Wang; Xiaofei Li; Lingyan Xu; Wentong Fang; Xiaomin Cai; Ying Wang; Jiawei Wang; Yuanyuan Wang; Fengjiao Zhao; Yanhong Gu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

6.  Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).

Authors:  Paolo Pedrazzoli; Nicola Silvestris; Antonio Santoro; Simona Secondino; Oronzo Brunetti; Vito Longo; Elena Mancini; Sara Mariucci; Teresa Rampino; Sara Delfanti; Silvia Brugnatelli; Saverio Cinieri
Journal:  ESMO Open       Date:  2017-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.